,,iii  #aag? ,,congress  #b;d ,session  
,s4 ,,res4 #efi  ,,9 ,,! ,,s5ate ,,( ,,!
 ,,unit$ ,,/ates  ,m>* #cj1 #bjbb,mr4   
,br[n 7= himself & ,mr4 ,sullivan7      
submitt$ ! foll[+ resolution2 :i* 0     
ref]r$ to ! ,committee on ,=eign        
,relations  ,,resolution  ,support+ !   
goals ( ,_w ,tub]culosis ,day to raise  
aw>5ess ab\t tub]culosis4  ,:]eas1 9    
#bjbj1 ne>ly  ( ! global population 0   
infect$ ) ! tub]culosis bact]ium 7ref]r$
 to 9 ?is preamble z ,,tb72 ,:]eas ! ,_w
 ,heal? ,organization 7ref]r$ to 9 ?is  
preamble z ! ,,:o7 e/imates t #i1ijj1jjj
 p develop$ ,,tb 9 #bjbj1 #h p]c5t ( :om
 7 also infect$ ) ! human               
immunodefici5cy virus 7ref]r$ to 9 ?is  
preamble z ,,hiv72 ,:]eas1 9 #bjbj1 ,,tb
 kill$ an e/imat$ #a1ead1jjj p1 second  
only to coronavirus disease #bjai       
7ref]r$ to 9 ?is preamble z ,,covid-#ai7
 z a lead+ cause ( dea? f a s+le        
infecti\s ag5t2 ,:]eas1 globally 9      
#bjbj1 an e/imat$ #a1ajj1jjj *ildr5     
develop$ ,,tb1 & 9 #bjbj1 #bbh1igb      

*ildr5 di$ ( ,,tb2 ,:]eas #b_/c ( new   
,,tb infections 9 #bjbj occurr$ 9 #h    
c\ntries3 ,india1 ,indonesia1 ,*9a1 !   
,philipp9es1 ,paki/an1 ,nig]ia1         
,banglade%1 & ,s\? ,africa2 ,:]eas ,,tb 
is a lead+ kill] ( p infect$ ) ,,hiv1 & 
#bad1jjj p ) ,,hiv di$ ( ,,tb 9 #bjbj2  
,:]eas vuln]able populations also at    
high risk = develop+ ,,tb include       
individuals :o are pregnant & newborns2 
,:]eas1 9 #bjbj1 ,,tb 0 ! #ac? lead+    
cause ( dea?2 ,:]eas1 9 "s sett+s1 wom5 
) ,,tb c face /igma1 discrim9ation1 &   
o/racization by _! families &           
communities2 ,:]eas ! global ,,tb       
epidemic & ! spread ( drug-resi/ant ,,tb
 pres5t a p]si/5t public heal? ?reat to 
! ,unit$ ,/ates because ! disease does n
 recognize bord]s2 ,:]eas               
antibiotic-resi/ant pa?og5s are a gr[+  
problem worldwide1 & drug-resi/ant ,,tb 
c occur :5 ! drugs us$ to treat ,,tb are
 mismanag$ or n made consi/5tly         
accessible2 ,:]eas /udies h demon/rat$  
direct p]son-to-p]son transmission (    

drug-resi/ant ,,tb2 ,:]eas multi-drug   
resi/ant ,,tb 7ref]r$ to 9 ?is preamble 
z ,,mdr-,,tb7 is caus$ by bact]ia )     
resi/ance to rifamp9 & isoniazid1 ! #b  
mo/ pot5t treatm5ts = ,,tb infection2   
,:]eas1 9 #bjbj1 accord+ to ! #bjba ,,:o
 ,global ,tub]culosis ,report1 an       
e/imat$ #c to #d p]c5t ( all new ,,tb   
cases & #ah to #ba p]c5t ( previ\sly    
treat$ cases 7 ,,mdr-,,tb or            
rifamp9-resi/ant ,,tb2 ,:]eas1 9 #bjbj1 
an e/imat$ #big1jjj p ar\nd ! _w        
develop$ ,,mdr-,,tb or rifamp9-resi/ant 
,,tb1 yet only approximately #a 9 #c (  
^? individuals 7 id5tifi$ & treat$2     
,:]eas ext5sively drug-resi/ant ,,tb    
7ref]r$ to 9 ?is preamble z ,,xdr-,,tb7 
is a r>e type ( ,,tb t is resi/ant to   
ne>ly all m$ic9es1 & !re=e c be v       
difficult & exp5sive to treat1          
especially among pati5ts ) ,,hiv2       
,:]eas1 9 #bjbj1 #be1fha cases (        
,,xdr-,,tb 7 report$2 ,:]eas1 9 #bjbj1 !
 ,c5t]s = ,disease ,control & ,prev5tion
 7ref]r$ to 9 ?is preamble z ,,cdc7     

e/imat$ t ! av]age co/ ( treat+ a s+le  
pati5t ) ,,mdr-,,tb 9 ! ,unit$ ,/ates 0 
#ahb1ahf1 & ! av]age co/ ( treat+ a     
pati5t ) ,,xdr-,,tb 0 ev5 high] at      
#efg1gjh1 comp>$ ) #bj1baa to treat a   
pati5t ) drug-susceptible ,,tb2 ,:]eas1 
betwe5 #bjje & #bjjg1 accord+ to an     
analysis by ! ,,cdc1 ,,mdr-,,tb &       
,,xdr-,,tb cases 9 ! ,unit$ ,/ates      
collectively co/ ! heal? c>e sy/em an   
e/imat$ #ec1jjj1jjj2 ,:]eas ! ,,cdc     
e/imates t co/s result+ f all =ms ( ,,tb
 9 ! ,unit$ ,/ates total$ m ?an         
#ejc1jjj1jjj 9 #bjbj2 ,:]eas1 9 a #bjjj 
report1 ! ,in/itute ( ,m$ic9e f\nd t a  
decrease 9 ,,tb control fund+ & ! spread
 ( ,,hiv & acquir$ immune defici5cy     
syndrome 7commonly ref]r$ to z ,,aids7  
caus$ a resurg5ce ( ,,tb 9 ! late #aihjs
 & e>ly #aiijs2 ,:]eas a total ( #g1agd 
,,tb cases 7 report$ 9 ! ,unit$ ,/ates 9
 #bjbj1 repres5t+ all #ej ,/ates & !    
,di/rict ( ,columbia1 & up to           
#ac1jjj1jjj p 9 ! ,unit$ ,/ates are     
e/imat$ to be liv+ ) lat5t ,,tb         

infection2 ,:]eas ! rate ( ,,tb disease 
9 ,african ,am]icans is #h4e times high]
 ?an ! rate ( disease 9 ,:ite1          
non-,hispanic ,am]icans1 & significant  
disp>ities exi/ among o!r m9orities 9 ! 
,unit$ ,/ates1 includ+ ,asian ,am]icans1
 ,hispanic ,am]icans1 & ,native         
,am]icans & ,alaska ,natives1 )         
approximately #hi p]c5t ( all report$   
,,tb cases 9 ! ,unit$ ,/ates 9 #bjbj    
occurr+ 9 racial or e?nic m9orities2    
,:]eas smok+-- 7#a7 greatly increases ! 
risks ( contract+ ,,tb & infection      
recurr5ce2 &  7#b7 impairs !rapeutic    
efficacy2 ,:]eas diabetes is a major    
risk factor = ,,tb1 & p ) diabetes are m
 likely to develop & succumb to ,,tb2   
,:]eas b$aquil9e is an antibiotic t     
boo/s ! *ance ( survival = an ,,mdr-,,tb
 pati5t f approximately #ej p]c5t to z  
mu* z #hj p]c5t1 & ?r\gh a              
public-private p>tn]%ip1 ! ,unit$ ,/ates
 ,ag5cy = ,int]national ,developm5t     
7ref]r$ to 9 ?is preamble z ,,usaid7    
provid$ approximately #aje1jjj treatm5ts

 9 #aaj eligible c\ntries f #bjae ?r\gh 
#bjai2 ,:]eas ,bacillus ,calmette-,gu]91
 a ,,tb vacc9e t is kn[n z ,,bcg1       
provides "s protection to infants & "y  
*ildr5 aga9/ s]i\s =ms ( *ildhood ,,tb b
 has _h little epidemiologic impact on  
controll+ ,,tb worldwide2 ,:]eas !re is 
a critical ne$ = new drugs1 diagno/ics1 
& vacc9es = controll+ ! global ,,tb     
epidemic2 ,:]eas1 9 ,septemb] #bjah1 !  
,unit$ ,nations held ! fir/ high-level  
meet+ on ,,tb at :i* #abj c\ntries1     
includ+ ! ,unit$ ,/ates1 sign$ a        
political decl>ation committ+ to        
accel]at+ ! ,,tb response1 includ+ by   
increas+ fund+ = ,,tb control programs &
 rese>* & developm5t ef=ts1 ) ! goal (  
rea*+ all affect$ p ) ,,tb prev5tion &  
c>e2 ,:]eas ! enactm5t ( ! ,tom ,lantos 
& ,h5ry ,j4 ,hyde ,unit$ ,/ates ,global 
,lead]%ip ,aga9/ ,,hiv_/,,aids1         
,tub]culosis1 & ,mal>ia ,reau?orization 
,act ( #bjjh 7,public ,law #aaj-bic2    
#abb ,/at4 #biah7 & ! ,compreh5sive     
,tub]culosis ,elim9ation ,act ( #bjjh   

7,public ,law #aaj-cib2 #abb ,/at4      
#daie7 l$ to a hi/oric ,unit$ ,/ates    
commitm5t to support ! global           
eradication ( ,,tb1 includ+ a commitm5t 
to treat #d1ejj1jjj ,,tb pati5ts &      
#ij1jjj ,,mdr-,,tb pati5ts betwe5 #bjji 
& #bjac & to provide additional treatm5t
 ?r\gh coord9at$ multilat]al ef=ts2     
,:]eas ,,usaid-- 7#a7 provides te*nical 
assi/ance to #ee c\ntries & implem5ts   
bilat]al programs 9 #bc high-burd5 ,,tb 
c\ntries t-- 7,a7 build capacity2 &     
7,b7 support ! adoption ( /ate-(-!-art  
,,tb-relat$ te*nologies2  7#b7 supports 
! developm5t ( new diagno/ic & treatm5t 
tools2 &  7#c7 supports rese>* to       
develop new vacc9es & o!r new me?ods to 
combat ,,tb2 ,:]eas1 9 #bjah1 ,,usaid   
laun*$-- 7#a7 a new bus9ess model       
entitl$ ,global ,accel]ator to ,end     
,tub]culosis to accel]ate progress &    
build capacity ) respect to ,,tb        
prev5tion & treatm5t2 &  7#b7 a new     
me*anism to directly support local      
organizations 9 priority c\ntries2      

,:]eas ,,tb incid5ce 9 ! c\ntries t     
receive bilat]al ,,tb fund+ f ! ,unit$  
,/ates ?r\gh ,,usaid has decreas$ by m  
?an #bi p]c5t s9ce #bjjj2 ,:]eas1       
accord+ to ! ,cop5hag5 ,cons5sus ,c5t]1 
,,tb prev5tion programs return #ef = ea*
 doll> inve/$1 :i* is "o ( ! highe/     
returns on inve/m5t ( any heal?         
int]v5tion2 ,:]eas ! ,,cdc1 9 p>tn]%ip )
 o!r entities ( ! ,unit$ ,/ates &       
individual ,/ates & t]ritories-- 7#a7   
directs ! national ,,tb elim9ation      
program2  7#b7 coord9ates ,,tb          
surveillance1 te*nical assi/ance1 &     
prev5tion activities2 &  7#c7 helps to  
support ! developm5t ( new diagno/ic1   
treatm5t1 & prev5tion tools to combat   
,,tb2 ,:]eas ! ,national ,in/itutes (   
,heal?1 ?r\gh its _m in/itutes & c5t]s1 
plays ! lead+ role 9 basic & cl9ical    
rese>* on ! id5tification1 treatm5t1 &  
prev5tion ( ,,tb2 ,:]eas ! ,global ,fund
 to ,fight ,,aids1 ,tub]culosis &       
,mal>ia 7ref]r$ to 9 ?is preamble z !   
,global ,fund71 to :i* ! ,unit$ ,/ates  

is a top f9ancial donor1 provides m ?an 
#gg p]c5t ( all int]national f9anc+ =   
,,tb programs2 ,:]eas1 9 #bjbj1 programs
 support$ by ! ,global ,fund detect$ &  
treat$ m ?an #d1gjj1jjj cases ( ,,tb2   
,:]eas ! ,,covid-#ai p&emic & mitigation
 ef=ts put 9 place z a result ( ! p&emic
 h tak5 a deva/at+ toll on c\ntries ) ! 
highe/ burd5 ( ,,tb disease & on !      
global ,,tb response1 ?reat5+ to rev]se 
up to #h ye>s ( progress fight+ !       
disease2 ,:]eas1 9 #bjbj1 9 ! #bc       
high-burd5 ,,tb c\ntries 9 :i* ,,usaid  
implem5ts bilat]al programs1 #a1jjj1jjj 
few] p ) ,,tb _h access to diagnosis &  
treatm5t1 a #bc p]c5t decl9e f #bjai2   
,:]eas1 betwe5 #bjbj & #bjbe1 global    
projections e/imate t ! impact ( !      
,,covid-#ai p&emic w lead to an         
additional #f1cjj1jjj cases ( ,,tb & an 
additional #a1djj1jjj ,,tb dea?s2 &     
,:]eas ,m>* #bd1 #bjbb1 is ,_w          
,tub]culosis ,day1 a day t commemorates 
! date 9 #ahhb on :i* ,dr4 ,rob]t ,ko*  
ann\nc$ 8 discov]y ( mycobact]ium       

tub]culosis1 ! bact]ium t causes ,,tb3  
,n[1 !re=e1 be x ,t ! ,s5ate-- 7#a7     
supports ! goals ( ,_w ,tub]culosis ,day
 to raise aw>5ess ab\t tub]culosis2     
7#b7 comm5ds ! progress ( tub]culosis   
elim9ation ef=ts by entities t include !
 ,unit$ ,/ates ,ag5cy = ,int]national   
,developm5t1 ! ,c5t]s = ,disease        
,control & ,prev5tion1 ! ,national      
,in/itutes ( ,heal?1 ! ,_w ,heal?       
,organization1 & ! ,global ,fund to     
,fight ,,aids1 ,tub]culosis & ,mal>ia2 &
  7#c7 reaffirms ! commitm5t to /r5g!n !
 lead]%ip role ( ! ,unit$ ,/ates 91 & ! 
effectiv5ess ( ! global response to1 !  
fight to end ! tub]culosis epidemic4